Iliana Karaoglan

She also has extensive experience advising on general corporate matters, including reporting requirements, corporate governance issues and other strategic considerations.

Iliana received her J.D., magna cum laude, from the University of Houston Law Center in 2014, where she was also the Symposium Editor of the Houston Law Review. She received her B.A. from the University of Virginia in 2009.

Experience

• Dun & Bradstreet Holdings Inc. in its pending $7.7 billion sale to Clearlake Capital Group
• Vonage Holdings Corp. in its $6.2 billion sale to Telefonaktiebolaget LM Ericsson
• Covetrus, Inc. in its $4 billion take private sale to CD&R and TPG
• Sanofi in multiple transactions, including its approximately $3.2 billion acquisition of Translate Bio, Inc.; its up to $1.35 billion acquisition of Kymab, Ltd; and its up to $470 million acquisition of Tidal Therapeutics, Inc.
• Blackstone in the $2.6 billion sale of ARKA Group to CACI
• MGM Resorts International in multiple transactions, including its $1.625 billion acquisition of the operations of The Cosmopolitan of Las Vegas; its $1.075 billion sale of the operations of The Mirage Hotel & Casino on the Las Vegas Strip to Hard Rock International; and its approximately $607 million acquisition of LeoVegas AB
• American Securities LLC in the $1.85 billion sale of its portfolio company ASP Acuren Holdings Inc.
• Thomas H. Lee Partners in its acquisition of a majority stake in Standish Management
• AMC Entertainment Holdings, Inc. in its $600 million issuance of senior unsecured convertible notes to Silver Lake to finance AMC's repurchase of a portion of its stock held by Dalian Wanda Group Co., AMC's majority owner, and to pay a special dividend
• Vivial Media Holdings, Inc. (f/k/a Vivial Media LLC) (a portfolio company of Blackstone Credit) and its subsidiary mGage in the $215 million sale of mGage to Kaleyra, Inc.
• The Kroger Company in its sale of its specialty pharmacy business to CarelonRx Inc.
• Iron Mountain Incorporated its up to $200 million carve-out acquisition of Regency Technologies
• GTCR in its (i) acquisition of FMG Suite and (ii) strategic, structured minority investment in Solmetex
• Blackstone and its portfolio company Sphera in connection with a significant growth investment in Sphera by client funds of Neuberger Berman Capital Solutions
• Insys Therapeutics, Inc. in its 363 asset sale transactions with each of: (i) Benuvia Therapeutics Inc., (ii) BTcP Pharma, LLC, Hikma Pharmaceuticals USA Inc., (iii) Pharmbio Korea, Inc., (iv) Renaissance Lakewood, LLC, and (v) Senzer Limited, and in connection with other strategic matters (Specialty Pharmaceuticals)
• Discovery, Inc. in its joint venture with Magnolia, the home and lifestyle brand led by Chip and Joanna Gaines, in the formation of the Magnolia Network
• Eli Lilly and Company in its global licensing and research collaboration with, and equity investment in, Dicerna Pharmaceuticals, Inc.
• Avon Products, Inc. in its sale of substantially all of its assets to Natura &Co and its affiliates, effected through a $125 million credit bid in connection with its chapter 11 proceedings
• Insys Therapeutics, Inc. in its asset sale transactions with Benuvia Therapeutics Inc. (f/k/a Chilion Group Holdings US, Inc.), BTcP Pharma, LLC, Hikma Pharmaceuticals USA Inc., Pharmbio Korea, Inc., Renaissance Lakewood, LLC and Senzer Limited, and in connection with other strategic matters
• The Mark Anthony Group in connection with the formation of the Más+ by Messi hydration beverage business, an international product venture with Lionel Messi, including related equity and licensing arrangements
• Waypoint Leasing (Ireland) Limited in the aggregate $650 million sale in bankruptcy of (i) a majority of its aircraft to Macquarie Rotorcraft Leasing Limited, and (ii) the balance of its aircraft to its secured lenders through a series of separate credit bid transactions

*Includes matters handled prior to joining Weil.